Mira Pharmaceuticals Files 8-K
Ticker: MIRA · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event
TL;DR
Mira Pharma filed an 8-K, but it's light on details.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on July 29, 2025, reporting an event under 'Other Events'. The filing does not contain specific details about the event, dollar amounts, or names beyond the company itself and its former name, Mira1a Therapeutics, Inc., which was changed on January 12, 2022.
Why It Matters
This filing indicates a corporate event has occurred, but lacks specific details, making it difficult to assess immediate impact.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure without immediate financial or operational implications detailed.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- January 12, 2022 (date) — Date of name change
- July 29, 2025 (date) — Date of report
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond the general category.
When did Mira Pharmaceuticals, Inc. change its name from Mira1a Therapeutics, Inc.?
The name change from Mira1a Therapeutics, Inc. to Mira Pharmaceuticals, Inc. occurred on January 12, 2022.
What is the principal executive office address for Mira Pharmaceuticals, Inc.?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the telephone number for Mira Pharmaceuticals, Inc.?
The registrant's telephone number, including area code, is (786) 432-9792.
What is the SIC code for Mira Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Mira Pharmaceuticals, Inc. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).